Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

1.9K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.9K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

1.0K
Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
1.0K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

3.6K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chalcone and <i>Trans</i>-Chalcone Induce Transcriptomic Changes in <i>Caenorhabditis elegans</i> Compatible with a Novel Cumulative Damage Mode of Action.

Molecules (Basel, Switzerland)·2026
Same author

Antileishmanial and Immunomodulatory Activity of Paclitaxel and Docetaxel Combined with Miltefosine and Paromomycin.

International journal of molecular sciences·2026
Same author

Development of a High-Throughput Screening Platform and a Pathogenesis Model for <i>Leishmania</i> Infection Based on Mouse Hepatic Organoids.

International journal of molecular sciences·2025
Same author

An Ovine Intestinal Organoid-Macrophage Co-Culture Model to Test the Effects of Ovine Colostrum Exosomes on Intestinal Barrier Function and Inflammation.

International journal of molecular sciences·2025
Same author

Discovery of Potential Antileishmanial Compounds Through Phenotypic Screening of an Alkaloid Library.

Molecules (Basel, Switzerland)·2025
Same author

Polyamine Induction of Secondary Metabolite Biosynthetic Genes in Fungi Is Mediated by Global Regulator LaeA and α-NAC Transcriptional Coactivator: Connection to Epigenetic Modification of Histones.

Molecules (Basel, Switzerland)·2025

Related Experiment Video

Updated: Jan 13, 2026

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

8.8K

Anticancer Secondary Metabolites Produced by Fungi: Potential and Representative Compounds.

Carlos García-Estrada1,2,3, Carlos Barreiro3,4,5, Juan F Martín6

  • 1Departamento de Ciencias Biomédicas, Facultad de Veterinaria, Universidad de León, Campus de Vegazana s/n, 24007 León, Spain.

International Journal of Molecular Sciences
|January 10, 2026
PubMed
Summary

Fungi are a rich source of novel anticancer compounds with diverse mechanisms of action, offering potential solutions to drug resistance in cancer therapy.

Keywords:
andrastinsanticancerantitumorclavaric acidfumitremorgin Cfungipaclitaxelsecondary metabolites

More Related Videos

Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks
09:18

Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks

Published on: December 2, 2022

1.4K
Isolation and Purification of Fungal &#946;-Glucan as an Immunotherapy Strategy for Glioblastoma
10:02

Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma

Published on: June 2, 2023

2.5K

Related Experiment Videos

Last Updated: Jan 13, 2026

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

8.8K
Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks
09:18

Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks

Published on: December 2, 2022

1.4K
Isolation and Purification of Fungal &#946;-Glucan as an Immunotherapy Strategy for Glioblastoma
10:02

Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma

Published on: June 2, 2023

2.5K

Area of Science:

  • Mycology
  • Natural Product Chemistry
  • Cancer Therapeutics

Background:

  • Cancer remains a leading global cause of death, with drug resistance necessitating novel therapeutic agents.
  • Natural sources, particularly fungi, are increasingly explored for unique anticancer compounds.
  • Fungal metabolites exhibit diverse chemical structures and antitumor properties.

Purpose of the Study:

  • To review potential antitumor compounds derived from fungal sources.
  • To discuss the characteristics and biosynthesis of key fungal-derived antitumor agents.
  • To explore the scientific debate surrounding fungal paclitaxel biosynthesis.

Main Methods:

  • Literature review of fungal-derived antitumor compounds.
  • Analysis of chemical structures and biosynthetic pathways of selected fungal metabolites.
  • Discussion of current research and scientific debates on fungal anticancer agents.

Main Results:

  • Fungi produce a wide array of secondary metabolites with potent antitumor activities.
  • Representative fungal antitumor compounds include sterols, prenylated diketopiperazines, and meroterpenoids.
  • Fungal compounds act through various mechanisms, including apoptosis induction and inhibition of metastasis.

Conclusions:

  • Fungal natural products represent a valuable reservoir for developing new anticancer drugs.
  • These compounds offer novel mechanisms of action to combat cancer drug resistance.
  • Further research into fungal biosynthesis and compound characterization is crucial for drug development.